Effect of topical vancomycin powder on surgical site infection prevention in major orthopaedic surgery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

• Published in: The Journal of hospital infection Vol. 150; pp. 105 - 113
• Main Authors: Saka, N., Yamada, K., Ono, K., Iwata, E., Mihara, T., Uchiyama, K., Watanabe, Y., Matsushita, K.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.08.2024
• Subjects: Administration, Topical; Anti-Bacterial Agents - administration & dosage; Antibiotic Prophylaxis - methods; Humans; Orthopaedic surgery; Orthopedic Procedures - adverse effects; Powders; Randomized Controlled Trials as Topic; Surgical site infection; Surgical Wound Infection - prevention & control; Topical antibiotics; Treatment Outcome; Vancomycin; Vancomycin - administration & dosage; Surgical site infection; Vancomycin; Topical antibiotics; Orthopaedic surgery
• ISSN: 0195-6701; 1532-2939; 1532-2939
• DOI: 10.1016/j.jhin.2024.04.028

Evidence has been mixed regarding the effect of topical vancomycin (VCM) powder in reducing surgical site infection (SSI). To clarify the effect of topical VCM powder for the prevention of SSI in major orthopaedic surgeries. The MEDLINE, Embase, CENTRAL, ICTRP, and ClinicalTrials.gov databases were searched from their inception to September 25th, 2023. Randomized controlled trials comparing topical VCM powder and controls for the prevention of SSI in major orthopaedic surgeries were included. Two reviewers independently screened the title and abstract and extracted relevant data, followed by the assessment of the risk of bias and the certainty of the evidence. Main outcome measures were overall SSI, reoperation, and adverse events. Summary results were obtained using random-effects meta-analysis. Trial sequential analysis (TSA) was performed. Eight randomized controlled trials yielded data on 4307 participants. VCM powder showed no difference in reducing overall SSI. The cumulative number of patients did not exceed the required information size of 19,233 in our TSA, and the Z-curves did not cross the trial sequential monitoring or futility boundary, suggesting an inconclusive result of the meta-analysis. No difference was found for reoperation. Among SSIs, VCM powder showed a statistically significant difference in reducing Gram-positive cocci SSI. However, the certainty of this evidence was very low. This systematic review and meta-analysis suggests inconclusive results regarding the effect of VCM powder in reducing SSI in major orthopaedic surgeries. Further trials using rigorous methodologies are required to elucidate the effect of this intervention.